Composition for Preventing and Treating Degenerative Brain Disease Using Novel Lactic Acid Bacteria

USPTO Patent Application US 2018/0148801 A1
Application Date: May 31st, 2018

ABSTRACT

Provided is a composition containing Lactobacillus reuteri ELF corresponding to a novel lactic acid bacteria strain and 5-aminolevulinic acid. The composition may be significantly effective to prevent and treat degenerative...
Application Number:
15/701,928
International Classification:
C12R 1/225 (20060101); A61K 35/747 (20060101); A61K 31/195 (20060101); A23L 33/135 (20060101); A23L 33/00 (20060101); A23L 33/10 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1. A novel Lactobacillus reuteri ELF (accession Number: KCTC 13154BP).

DESCRIPTION

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to Korean Patent Application Nos. 10-2016-0160188 and 10-2017-0103015, filed Nov. 29, 2016 and Aug. 14, 2017, respectively, the disclosures of which are hereby incorporated in their entirety by reference.
Back to Top